IP Library › Assignment 069585/0667
Patent Assignment
Reel/Frame 069585/0667

Termination and Release of Patent Security Agreement

Recorded: 2024-12-10 Pages: 41
Assignor
IEH BIOPHARMA, LLC
Executed: 2024-12-10
Assignee
VIVUS LLC (F/K/A VIVUS, INC.)
900 EAST HAMILTON AVENUE, SUITE 550, CAMPBELL, CALIFORNIA, 95008
Covered Properties (34)
On Demand Administration of Clomipramine and Salts Thereof to Treat Premature Ejaculation
Patent: 6,495,154 →
Application: 09/721,412 →
As-Needed Administration of Tricyclic and Other Non-Sri Antidepressant Drugs to Treat Premature Ejaculation
Patent: 6,946,141 →
Application: 09/996,407 →
Publication: US 2002/0161016
Combination Therapy for Treatment of Sleep Apnea
Patent: 8,802,636 →
Application: 12/683,353 →
Publication: US 2010/0105765
Combination Therapy for Effecting Weight Loss and Treating Obesity
Application: 16/732,544 →
Publication: US 2020/0129474
Combination Therapy for Effecting Weight Loss and Treating Obesity
Patent: 7,056,890 →
Application: 10/454,368 →
Publication: US 2004/0002462
Combination Therapy for Effecting Weight Loss and Treating Obesity
Patent: 7,659,256 →
Application: 11/385,199 →
Publication: US 2006/0234951
Combination Therapy for Effecting Weight Loss and Treating Obesity
Patent: 7,553,818 →
Application: 11/385,198 →
Publication: US 2006/0234950
Combination Therapy for Effecting Weight Loss and Treating Obesity
Patent: 7,674,776 →
Application: 11/385,233 →
Publication: US 2006/0234952
Treatment Of Pulmonary Hypertension With Carbonic Anhydrase Inhibitors
Patent: 8,536,138 →
Application: 13/311,476 →
Publication: US 2012/0196881
Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors
Patent: 8,071,557 →
Application: 11/818,306 →
Publication: US 2008/0312163
Low Dose Topiramate/Phentermine Composition And Methods Of Use Thereof
Patent: 8,895,058 →
Application: 14/048,576 →
Publication: US 2014/0037723
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity
Patent: 8,895,057 →
Application: 14/048,416 →
Publication: US 2014/0187623
Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof
Patent: 9,011,905 →
Application: 14/495,246 →
Publication: US 2015/0010625
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
Patent: 9,011,906 →
Application: 14/495,250 →
Publication: US 2015/0010626
Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof
Application: 16/796,189 →
Publication: US 2020/0188313
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
Application: 16/796,194 →
Publication: US 2020/0188352
Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof
Patent: 8,580,298 →
Application: 12/481,540 →
Publication: US 2010/0215739
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
Patent: 8,580,299 →
Application: 12/481,548 →
Publication: US 2009/0304785
Methods of Preventing Progression to Type 2 Diabetes Mellitus
Patent: 9,724,327 →
Application: 14/509,297 →
Publication: US 2015/0099801
Methods of Preventing Progression to Type 2 Diabetes Mellitus
Application: 15/639,972 →
Publication: US 2018/0055818
Methods of Preventing Progression to Type 2 Diabetes Melitus
Application: 16/733,559 →
Publication: US 2020/0179332
Orally Disintegrating Dosage Form for Administration of Avanafil, and Associated Methods of Manufacture and Use
Application: 14/714,028 →
Publication: US 2016/0331687
Orally Disintegrating Dosage Form for Administration of Avanafil, and Associated Methods of Manufacture and Use
Application: 16/590,703 →
Publication: US 2020/0030239
Orally Administrable Formulations for the Controlled Release of a Pharmacologically Active Agent
Application: 16/108,396 →
Publication: US 2019/0209595
Orally Administrable Formulations for the Controlled Release of a Pharmacologically Active Agent
Application: 16/822,308 →
Publication: US 2020/0215091
Treatment of Sleep Apnea with a Combination of a Carbonic Anhydrase Inhibitor and an Aldosterone Antagonist
Application: 16/296,436 →
Publication: US 2020/0069716
Methods and Compositions for the Treatment of Non-Alcoholic Steatohepatitis
Application: 16/251,231 →
Publication: US 2019/0374505
Combination Therapy for Pulmonary Hypertension
Application: 16/381,128 →
Publication: US 2020/0069658
Compositions and Methods for the Treatment or Prevention of Pulmonary Hypertension
Application: 16/360,114 →
Publication: US 2020/0054613
Methods of Treating Obesity in Responder and Non-Responder Populations
Application: 16/007,420 →
Publication: US 2019/0142786
Methods of Regulating Access to Qsymia to Mitigate Potential Drug-Associated Risks
Application: 16/732,508 →
Publication: US 2020/0135318
Anticonvulsant derivatives useful in reducing blood glucose levels
Patent: 6,362,220 →
Application: 09/538,803 →
Anticonvulsant derivatives useful in lowering blood pressure
Patent: 6,201,010 →
Application: 09/538,182 →
Anticonvulsant derivatives useful in lowering lipids
Patent: 6,191,163 →
Application: 09/538,185 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 16, 2001
From: TAM, PETER; GESUNDHEIT, NEIL; WILSON, LELAND F.
To: VIVUS INC.
Reel/Frame 011576/0839 →
Assignment of Assignor's Interest Mar 18, 2002
From: TAM, PETER; GESUNDHEIT, NEIL; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 012492/0234 →
Assignment of Assignor's Interest Aug 27, 2003
From: NAJARIAN, THOMAS
To: VIVUS, INC.
Reel/Frame 013919/0326 →
Assignment of Assignor's Interest Oct 24, 2006
From: NAJARIAN, THOMAS
To: VIVUS, INC.
Reel/Frame 018429/0910 →
Assignment of Assignor's Interest Oct 24, 2006
From: NAJARIAN, THOMAS
To: VIVUS, INC.
Reel/Frame 018430/0015 →
Assignment of Assignor's Interest Oct 24, 2006
From: NAJARIAN, THOMAS
To: VIVUS, INC.
Reel/Frame 018429/0954 →
Assignment of Assignor's Interest Jun 13, 2007
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.; PETERSON, CRAIG
To: VIVUS, INC.
Reel/Frame 019490/0674 →
Assignment of Assignor's Interest Sep 14, 2009
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 023228/0097 →
Assignment of Assignor's Interest Sep 14, 2009
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 023228/0197 →
Assignment of Assignor's Interest Aug 2, 2010
From: NAJARIAN, THOMAS
To: VIVUS, INC.
Reel/Frame 024774/0697 →
Assignment of Assignor's Interest Apr 17, 2012
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.; PETERSON, CRAIG
To: VIVUS, INC.
Reel/Frame 028059/0924 →
Security Agreement Apr 9, 2013
From: VIVUS. INC.
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 030183/0029 →
Affidavit of Address Change Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0358 →
Affidavit of Address Change Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0356 →
Affidavit of Address Change Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0226 →
Affidavit of Address Change Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0429 →
Affidavit of Address Change Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0408 →
Affidavit of Address Change Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0397 →
Affidavit of Address Change Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0366 →
Affidavit of Address Change Oct 11, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031396/0240 →
Affidavit of Address Change Oct 11, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031396/0242 →
Affidavit of Address Change Oct 11, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031396/0200 →
Affidavit of Address Change Oct 11, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031396/0187 →
Assignment of Assignor's Interest Jan 30, 2015
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 034853/0846 →
Assignment of Assignor's Interest Jan 30, 2015
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 034854/0350 →